The Philadelphia Epidemic of Legionnaire's Disease: Clinical, Pulmonary, and Serologic Findings Two Years Later

  1. GARY L. LATTIMER, M.D.;
  2. LUTHER V. RHODES III, M.D.;
  3. JOHN S. SALVENTI, Ph.D.;
  4. JOHN P. GALGON, M.D.;
  5. VICTOR STONEBRAKER;
  6. SHARON BOLEY, B.S.; and
  7. GARY HAAS
  1. Allentown, Pennsylvania

    Abstract

    Clinical, pulmonary, and serologic findings in Legionnaires who attended the 1976 American Legion Convention in Philadelphia were studied 2 years after the Legionnaires' disease epidemic there. All 31 survivors of Legionnaires' disease studied became ill within 2 weeks after the convention, and 18 had not fully recovered 2 years after the epidemic. Twenty-five (28%) of 90 additional Legionnaires exposed at the convention but not diagnosed as having Legionnaires' disease became ill during the same time interval; five of these had symptoms during the next 2 years. Survivors had decreased diffusion capacities measured by the carbon monoxide single-breath method. These differences could not be accounted for by ventilation abnormalities or concurrent illness. Significant levels of IgG or IgM antibodies persisted in 94% of survivors of Legionnaires' disease and in 53% of Legionnaires exposed at the convention, which suggests a high prevalence of subclinical infection. Persistence of IgM antibody raises the question of latency or subclinical infection as part of the natural history of Legionnaires' disease.

    Article and Author Information

    • ▸From the Divisions of Infectious Diseases, Pulmonary Medicine, and Pathology, Allentown-Sacred Heart Hospital Center; Allentown, Pennsylvania.

    • ▸Requests for reprints should be addressed to Gary L. Lattimer, M.D.; Allentown-Sacred Heart Hospital Center; 1200 S. Cedar Crest Boulevard; Allentown, PA 18105.

      • Received November 15, 1978.
      • Accepted January 19, 1979.
    « Previous | Next Article »Table of Contents